Pharmacists in Mountain Home, Idaho


13 Pharmacists found in Mountain Home
female pharmacist

Caylin Lepire


Pharmacist
490 N 2nd E, Mountain Home, ID 83647
208-587-3346    

male pharmacist

Donald Toolson


Pharmacist
2745 American Legion Blvd, Mountain Home, ID 83647
208-587-0861    

male pharmacist

James Alexander, RPH


Pharmacist
270 N 2nd E, Mountain Home, ID 83647
208-587-3346     208-587-2052



male pharmacist

James Patrick Doyle, PHARMD


Pharmacist
528 N Main St, Mountain Home, ID 83647
208-587-3365     208-587-1545

male pharmacist

Jeff Jausoro


Pharmacist
528 N Main St, Mountain Home, ID 83647
208-587-3365     208-587-1545

male pharmacist

Dr. Joseph Pendleton, PHARMD


Pharmacist
2745 American Legion Blvd, Mountain Home, ID 83647
208-587-0861    

male pharmacist

Kory Dell Olaveson, PHARMD


Pharmacist
895 N 6th E, Mountain Home, ID 83647
208-587-0546    

male pharmacist

Lender Alger


Pharmacist
895 N 6th E, Mountain Home, ID 83647
208-587-0568    

female pharmacist

Mischa Pesicek


Pharmacist
2745 American Legion Blvd, Mountain Home, ID 83647
208-587-0861    

male pharmacist

Onome Benjamin Jonah, PHARMACIST


Pharmacist
2745 American Legion Blvd, Mountain Home, ID 83647
208-587-0861    

female pharmacist

Samantha Dodge, PHARM D


Pharmacist
490 N 2nd E, Mountain Home, ID 83647
208-587-3346    

female pharmacist

Tara Whitney, PHARMD


Pharmacist
528 N Main St, Mountain Home, ID 83647
208-587-3364    

female pharmacist

Tracy Lynn Bideganeta, RPH


Pharmacist
270 N 2nd E, Mountain Home, ID 83647
208-587-3346     208-587-2052


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.